Langerhans cells require signals from both tumour necrosis factor-alpha and interleukin-1 beta for migration

被引:298
|
作者
Cumberbatch, M
Dearman, RJ
Kimber, I
机构
[1] Zeneca Central Toxicology Laboratory, Macclesfield, Cheshire, Alderley Park
[2] Zeneca Central Toxicology Laboratory, Macclesfield, Cheshire, SK10 4TJ, Alderley Park
关键词
D O I
10.1046/j.1365-2567.1997.00360.x
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The induction phase of contact sensitization is associated with the movement of epidermal Langerhans cells (LC) from the skin and their migration, via afferent lymphatics, to draining lymph nodes where they accumulate as immunostimulatory dendritic cells (DC). It has been demonstrated previously that tumour necrosis factor-alpha (TNF-alpha) provides an important signal for LC migration and that in the absence of this cytokine, movement of LC from the epidermis to regional lymph nodes is inhibited. Recent evidence indicates that interleukin-1 beta (IL-1 beta), a cytokine produced in murine epidermis exclusively by LC, may also play a role in LC migration. The purpose of the investigations described here was to clarify, using relevant neutralizing anticytokine antibodies, the contributions made by TNF-alpha and IL-1 beta to the migration of LC from the epidermis. It was found that like anti-TNF-alpha, anti-IL-1 beta administered systemically to mice (by intraperitoneal injection), prior to skin sensitization with the contact allergen oxazolone, resulted in a marked inhibition of DC accumulation in draining lymph nodes. It was shown also that anti-IL-1 beta inhibited TNF-alpha-induced LC migration and DC accumulation and that, in similar fashion, the stimulation of LC migration and DC accumulation induced by IL-1 beta was compromised by prior treatment with anti-TNF-alpha. Based upon these data it is proposed that the stimulation of LC migration in response to skin sensitization requires the receipt by LC of two independent signals, one provided by TNF-alpha and the other by IL-1 beta. Morphological analyses of LC in epidermal sheets prepared from animals exposed to these cytokines with or without prior systemic treatment with anti-cytokine antibody suggested that the changes induced in LC by TNF-alpha and IL-1 beta may include the altered expression of adhesion molecules and acquisition of the ability to interact with and pass through the basement membrane.
引用
收藏
页码:388 / 395
页数:8
相关论文
共 50 条
  • [21] The role of interleukin-6, interleukin-1 beta, tumor necrosis factor-alpha and endotoxin in hepatic resection
    Shimada, M
    Matsumata, T
    Taketomi, A
    Shirabe, K
    Yamamoto, K
    Takenaka, K
    Sugimachi, K
    HEPATO-GASTROENTEROLOGY, 1995, 42 (05) : 691 - 697
  • [22] Interleukin 1β and the stimulation of Langerhans cell migration: comparisons with tumour necrosis factor α
    M. Cumberbatch
    R. J. Dearman
    I. Kimber
    Archives of Dermatological Research, 1997, 289 : 277 - 284
  • [23] METABOLIC EFFECTS OF TUMOR NECROSIS FACTOR-ALPHA (CACHECTIN) AND INTERLEUKIN-1
    EVANS, RD
    ARGILES, JM
    WILLIAMSON, DH
    CLINICAL SCIENCE, 1989, 77 (04) : 357 - 364
  • [24] Macrophage-colony stimulating factor but not macrophage migration inhibitory factor is regulated by tumor necrosis factor-alpha and interleukin-1 beta in human decidual cells.
    Arcuri, F
    Toti, P
    Vannoni, A
    Carducci, A
    Occhini, R
    Cintorino, M
    Lockwood, CJ
    Schatz, F
    JOURNAL OF THE SOCIETY FOR GYNECOLOGIC INVESTIGATION, 2006, 13 (02) : 134A - 135A
  • [25] Tumor necrosis factor-alpha, interleukin-1 beta, and interleukin-1 receptor antagonist in dialysate and serum from patients on continuous ambulatory peritoneal dialysis
    Brauner, A
    Hylander, B
    Wretlind, B
    AMERICAN JOURNAL OF KIDNEY DISEASES, 1996, 27 (03) : 402 - 408
  • [26] Increased production of tumour necrosis factor-alpha, interleukin-1 beta, and interleukin-6 by morphologically normal intestinal biopsies from patients with Crohn's disease
    Reimund, JM
    Wittersheim, C
    Dumont, S
    Muller, CD
    Kenney, JS
    Baumann, R
    Poindron, P
    Duclos, B
    GUT, 1996, 39 (05) : 684 - 689
  • [27] Tumor necrosis factor-alpha and interleukin-1 beta levels in children with bacterial, tuberculous and aseptic meningitis
    Ceyhan, M
    Kanra, G
    Ecevit, Z
    Secmeer, G
    Erdem, G
    Akan, O
    Muftuoglu, O
    TURKISH JOURNAL OF PEDIATRICS, 1997, 39 (02) : 177 - 184
  • [28] Association of Interleukin-1 beta and tumor necrosis factor-alpha genetic polymorphisms with gastric cancer in India
    Sultana, Zareen
    Bankura, Biswabandhu
    Pattanayak, Arup Kumar
    Sengupta, Debmalya
    Sengupta, Mainak
    Saha, Makhan Lal
    Panda, Chinmay Kumar
    Das, Madhusudan
    ENVIRONMENTAL AND MOLECULAR MUTAGENESIS, 2018, 59 (07) : 653 - 667
  • [29] Analysis of the local kinetics and localization of interleukin-1 alpha, tumour necrosis factor-alpha and transforming growth factor-beta, during the course of experimental pulmonary tuberculosis
    HernandezPando, R
    Orozco, H
    Arriaga, K
    Sampieri, A
    LarrivaSahd, J
    MadridMarina, V
    IMMUNOLOGY, 1997, 90 (04) : 607 - 617
  • [30] Serum levels of interleukin-1 receptor antagonist and tumor necrosis factor-alpha are elevated in children with langerhans cell histiocytosis
    Rosso, DA
    Ripoli, MF
    Roy, A
    Diez, RA
    Zelazko, ME
    Braier, JL
    JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY, 2003, 25 (06) : 480 - 483